New research led by the University of Birmingham suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease. The research, carried out in mice, cells in the laboratory, and using publicly available data from […]
COVID19's cytokine storm ushers in a local complement storm in the lungs
A new study published in the journal Science Immunology analyzed lung epithelial cells from patients infected with COVID-19 and found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces the complement system as a dangerous weapon for viral infection. The complement system is an extension of the innate immune system to recognize pathogens and remove […]
Study reveals arsenal used by protozoans to make leishmaniasis more severe
Researchers have succeeded in revealing the arsenal used by protozoans of the genus Leishmania in human cells to make leishmaniasis more severe, especially in cases of the mucocutaneous variety of the disease, which can cause deformations in patients. The discovery points the way to a search for novel treatments for the disease as well as […]
Researchers explore potential role of TARM1 protein in pathogenesis of rheumatoid arthritis
TARM1 is a receptor protein whose role in the functioning of the immune system is unknown. In a new study, scientists from Japan have explored the potential role of TARM1 in the pathogenesis of rheumatoid arthritis by analyzing mouse models. They found that TARM1 activated dendritic cells, and development of collagen-induced arthritis (CIA) was notably […]
CAR T-cell therapy produces deep, sustained remissions in patients with relapsed myeloma
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found. In a study posted online today by the New England Journal of Medicine, trial leaders report that almost 75% of the […]
Roferon-A
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Roferon-A pre-filled syringes. It does not contain all the available information. It does not take […]
Mabthera (NHL/CLL)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia pronounced (mab-thir-ra) contains the active ingredient rituximab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MabThera intravenous infusion.It […]
Vaqta
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VAQTA® Hepatitis A vaccine, Inactivated (hepatitis A virus, inactivated) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VAQTA.It does not contain all the available information. It does not take the place of talking to your […]
Trileptal
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRILEPTAL® oxcarbazepine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trileptal. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in […]
Thioprine 50
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. THIOPRINE 50 azathioprine film-coated tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Thioprine 50. It does not contain all the available information. It does not take the place of talking to your doctor or […]